TVTX 8-K 2026-09-21

Travere Therapeutics, Inc. (TVTX) 8-K dated 2026-09-21 — accession 0001438533-26-000068. This URL is the filing, not the TVTX hub.

Travere Therapeutics, Inc. (TVTX) is a biotechnology company listed on US.

Travere Therapeutics, Inc. filed a 8-K on 2026-09-21. Accession 0001438533-26-000068.

Cached items: 5.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported TVTX revenue for 2025-12-31 was $490.7M. Net income was -$25.5M. Revenue was up 110.5% from 2024-12-31 to 2025-12-31. TVTX currently screens at market cap $1.33B.

Not investment advice. The TVTX SEC hub lists recent forms. The stock page is the research view.